194 related articles for article (PubMed ID: 3498743)
1. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
Niwa J; Sato O; Tanabe S
Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
[TBL] [Abstract][Full Text] [Related]
4. Amino acid metabolism in pituitary adenomas.
Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Långström B
Acta Radiol Suppl; 1986; 369():412-4. PubMed ID: 2980512
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography applied in the study of pituitary adenomas.
Muhr C; Bergström M
J Endocrinol Invest; 1991 Jun; 14(6):509-28. PubMed ID: 1837798
[No Abstract] [Full Text] [Related]
6. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
7. Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-[11C]methionine and L-[11C]methionine.
Bergström M; Muhr C; Lundberg PO; Bergström K; Lundqvist H; Antoni G; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(3):384-9. PubMed ID: 3494753
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
Landolt AM; Minder H; Osterwalder V; Landolt TA
Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
[TBL] [Abstract][Full Text] [Related]
10. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
[TBL] [Abstract][Full Text] [Related]
11. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
[TBL] [Abstract][Full Text] [Related]
12. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
[TBL] [Abstract][Full Text] [Related]
13. [Radiological control of prolactin adenomas treated with bromocriptine].
Metzger J; Gardeur D; Pehuet M; Houlbert D
Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
[No Abstract] [Full Text] [Related]
14. Bromocriptine reduction of prolactinoma size.
Corenblum B; Hanley DA
Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
[TBL] [Abstract][Full Text] [Related]
15. Malignant prolactinoma with multiple intracranial metastases studied with positron emission tomography.
Muhr C; Bergström M; Lundberg PO; Hartman M; Bergström K; Pellettieri L; Långström B
Neurosurgery; 1988 Feb; 22(2):374-9. PubMed ID: 3258413
[TBL] [Abstract][Full Text] [Related]
16. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
[TBL] [Abstract][Full Text] [Related]
17. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Daemen BJ; Zwertbroek R; Elsinga PH; Paans AM; Doorenbos H; Vaalburg W
Eur J Nucl Med; 1991; 18(7):453-60. PubMed ID: 1915472
[TBL] [Abstract][Full Text] [Related]
18. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
[TBL] [Abstract][Full Text] [Related]
19. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
[TBL] [Abstract][Full Text] [Related]
20. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
Jones TH; Figueroa CD; Smith CM; Cullen DR; Bhoola KD
J Endocrinol; 1992 Jul; 134(1):149-54. PubMed ID: 1500840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
